S. Ramos, Kennedy https://orcid.org/0000-0002-0283-3765
Nassiri, Soufiane
Wijdeveld, Leonoor F. J.
van der Palen, Reinier L.
Kuipers, Myrthe F.
Hills, Mellanie True
Slijkerman, Pieter
van Raalte, Daniel H.
Handoko, M. Louis
de Groot, Natasja M. S.
Grewal, Nimrat
Klautz, Robert J. M.
Eringa, Etto C.
Brundel, Bianca J. J. M.
Funding for this research was provided by:
NWO (NWA 1389.20.157)
Netherlands Heart Foundation (CVON RECONNEXT)
Netherlands Heart Foundation (2020B008)
Innovation Exchange Amsterdam
Atrial-Fibrillation-Innovation-Platform
StopAfib.org
Article History
Accepted: 22 March 2025
First Online: 14 April 2025
Declarations
:
: The study is carried out in adherence to the Declaration of Helsinki and is approved by the local medical ethical committee of the Amsterdam University Medical Centra with the number MEC 2024.1014, recorded in the Clinical Trial Information System (CTIS) registry with the trial number 2024–514743-28–00.
: All patients provided written informed consent for participation before study entry.
: Not applicable.
: Authors B.J.J.M.B, M.F.K, and N.M.S.d.G are founders of Atrial-Fibrillation-Innovation-Platform (AFIPonline.org), and author M.T.H. is the founder of StopAfib.org, both non-profit organizations. All other authors declare no competing interest.